Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience

Although next-generation sequencing (NGS) has helped characterize the complex genomic landscape of myeloid malignancies, its clinical utility remains undefined. This has resulted in variable funding for NGS testing, limiting its accessibility. At our center, targeted sequencing (TAR-SEQ) using a 54-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hemasphere
Main Authors: Alduaij, Waleed, McNamara, Caroline J., Schuh, Andre, Arruda, Andrea, Sukhai, Mahadeo, Kanwar, Nisha, Thomas, Mariam, Spiegel, Jay, Kennedy, James A., Stockley, Tracy, Tsui, Hubert, Devlin, Rebecca, Sibai, Hassan, Maze, Dawn, Schimmer, Aaron, Yee, Karen, Chan, Steven, Kamel-Reid, Suzanne, Gupta, Vikas
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745993/
https://ncbi.nlm.nih.gov/pubmed/31723772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000044
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados